Published in Allergy Asthma Clin Immunol on October 08, 2012
Pathophysiological characterization of asthma transitions across adolescence. Respir Res (2014) 0.79
Have recent investigations into remission from childhood asthma helped in understanding the pathogenesis of this disease? Med Sci Monit (2015) 0.77
Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med (1996) 6.34
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med (2006) 4.83
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med (1996) 4.54
A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med (1998) 4.52
The role of Th1/Th2 polarization in mucosal immunity. Nat Med (2002) 3.19
T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol (1996) 2.92
An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet (2005) 2.39
The natural history of respiratory symptoms in a cohort of adolescents. Am J Respir Crit Care Med (1998) 2.05
Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med (1996) 1.97
Prospective study of risk factors for early and persistent wheezing in childhood. Eur Respir J (1995) 1.88
A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol (1998) 1.81
Epidemiology of childhood asthma. Lancet (1997) 1.65
Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am J Respir Cell Mol Biol (1999) 1.64
Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am J Respir Crit Care Med (2000) 1.59
Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis (1993) 1.54
Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med (1997) 1.31
T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production. Proc Natl Acad Sci U S A (2007) 1.29
Insights into the initiation of type 2 immune responses. Immunology (2011) 1.25
Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis (1992) 1.24
Outcome of asthma: longitudinal changes in lung function. Eur Respir J (1999) 1.15
Risk factors for the persistence of respiratory symptoms in childhood asthma. Am Rev Respir Dis (1993) 1.13
Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol (1997) 1.09
T cells and chronic asthma. Int Arch Allergy Immunol (1999) 1.06
Early childhood respiratory symptoms and the subsequent diagnosis of asthma. J Allergy Clin Immunol (1996) 1.02
Mechanisms of glucocorticoid-resistant asthma. Ann N Y Acad Sci (1998) 1.00
Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of IFN-gamma responses. J Allergy Clin Immunol (2002) 0.99
Evolution of asthma through childhood. Clin Exp Allergy (1998) 0.99
Sensitization to mite allergens is a risk factor for early and late onset of asthma and for persistence of asthmatic signs in children. J Allergy Clin Immunol (1995) 0.96
Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma. Clin Exp Allergy (1995) 0.96
Prognostic factors for the outcome of childhood asthma in adolescence. Thorax (1996) 0.96
Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression. Pediatrics (1997) 0.95
Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes. J Allergy Clin Immunol (2009) 0.94
Long-term outcome of early childhood wheezing: population data. Eur Respir J Suppl (1996) 0.92
Asymptomatic bronchial hyperreactivity and the development of asthma and other respiratory tract illnesses in children. Thorax (1994) 0.92
Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells. Methods (1997) 0.91
The epidemiology of childhood asthma. Allergy (1999) 0.90
Unique profile of IL-4 and IFN-gamma production by peripheral blood mononuclear cells in infants with atopic dermatitis. J Allergy Clin Immunol (1998) 0.90
The cellular and mediator basis of asthma in relation to natural history. Lancet (1997) 0.89
Asthma genetics: waiting to exhale. Nat Genet (1997) 0.88
Differential regulation of allergen-specific T(H2)- but not T(H1)-type responses by alveolar macrophages in atopic asthma. J Allergy Clin Immunol (1998) 0.86
Increased levels of IL-4 in CD8+ T cells in atopic asthma. J Allergy Clin Immunol (1997) 0.86
Immunologic basis of chronic allergic diseases: clinical messages from the laboratory bench. Pediatr Res (1997) 0.85
Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. Immunopharmacology (1996) 0.84
The structural and functional consequences of chronic allergic inflammation of the airways. Ciba Found Symp (1997) 0.83
Asymptomatic bronchial hyperresponsiveness in adolescents and young adults. Eur Respir J (1997) 0.82
Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: effect of glucocorticoid therapy. Clin Exp Allergy (1994) 0.82
Effect of anti-IL-4 and anti-IL-5 antibodies on allergic airway hyperresponsiveness in mice. Life Sci (1998) 0.82
Interleukin-18 and interleukin-18 receptor-α expression in allergic asthma. Eur Respir J (2011) 0.81
Extrinsic and intrinsic asthma from childhood to adult age: a 10-yr follow-up. Respir Med (1995) 0.81
Elevated interleukin-4 secretion by T lymphocytes: a feature of atopy or of asthma? Clin Exp Allergy (1995) 0.78
The etiology and control of bronchial hyperresponsiveness in children. Curr Opin Pediatr (1996) 0.77
Childhood antecedents of adult respiratory disease. Respirology (1997) 0.77
Th1 and Th2 cells are required for both eosinophil- and neutrophil-associated airway inflammatory responses in mice. Biochem Biophys Res Commun (2007) 0.77
Bronchial reactivity: hyporesponsiveness vs hyperresponsiveness. JAMA (1992) 0.76
Blood eosinophils, eosinophil-derived proteins, and leukotriene C4 generation in relation to bronchial hyperreactivity in children with atopic dermatitis. Allergy (1995) 0.76
Do eosinophil counts correlate differently with asthma severity by symptoms versus peak flow rate? Ann Allergy Asthma Immunol (1999) 0.76
Effect of bronchial allergen challenge on in vitro cytokine release by peripheral blood mononuclear cells of atopic patients. Allergy (1998) 0.76
Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. Am Rev Respir Dis (1992) 0.75
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med (2009) 5.90
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 3.98
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59
The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med (2008) 3.01
Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med (2011) 2.80
Omalizumab for asthma in adults and children. Cochrane Database Syst Rev (2014) 2.13
Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids. J Allergy Clin Immunol (2006) 1.93
New and emerging roles for mast cells in host defence. Curr Opin Immunol (2006) 1.88
Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol (2003) 1.71
Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma. J Allergy Clin Immunol (2010) 1.58
The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J Biol Chem (2004) 1.58
Safety of sputum induction in moderate-to-severe smoking-related chronic obstructive pulmonary disease. COPD (2006) 1.47
Asthma management by monitoring sputum neutrophil count. Chest (2008) 1.44
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. J Allergy Clin Immunol (2008) 1.43
Sample sizes for clinical trials using sputum eosinophils as a primary outcome. Eur Respir J (2013) 1.42
Success and failure in teaching the [r]-[l] contrast to Japanese adults: tests of a Hebbian model of plasticity and stabilization in spoken language perception. Cogn Affect Behav Neurosci (2002) 1.41
Clinical models to compare the safety and efficacy of inhaled corticosteroids in patients with asthma. Can Respir J (2003) 1.40
Enhancement of mast cell IL-6 production by combined toll-like and nucleotide-binding oligomerization domain-like receptor activation. Int Arch Allergy Immunol (2010) 1.40
Sputum CD34+IL-5Ralpha+ cells increase after allergen: evidence for in situ eosinophilopoiesis. Am J Respir Crit Care Med (2003) 1.21
Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop report. J Aerosol Med Pulm Drug Deliv (2012) 1.20
An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med (2004) 1.19
Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori. Infect Immun (2003) 1.15
Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J Immunol (2004) 1.13
Zinc metabolism in airway epithelium and airway inflammation: basic mechanisms and clinical targets. A review. Pharmacol Ther (2004) 1.12
Dengue virus selectively induces human mast cell chemokine production. J Virol (2002) 1.12
IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol (2004) 1.10
A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. J Immunol (2010) 1.10
Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol (2006) 1.07
Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens. J Immunol (2004) 1.07
The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med (2010) 1.06
Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood (2008) 1.03
Dengue virus infection of mast cells triggers endothelial cell activation. J Virol (2010) 1.02
Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. J Allergy Clin Immunol (2006) 1.01
LXR-induced reverse cholesterol transport in human airway smooth muscle is mediated exclusively by ABCA1. Am J Physiol Lung Cell Mol Physiol (2008) 0.98
Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol (2010) 0.98
Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples. J Allergy Clin Immunol (2010) 0.97
Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids. Mol Nutr Food Res (2013) 0.96
A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol (2006) 0.95
Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation. Immunobiology (2008) 0.95
RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. PLoS One (2012) 0.95
Use of a zinc fluorophore to measure labile pools of zinc in body fluids and cell-conditioned media. Biotechniques (2006) 0.94
Predictors of loss of asthma control induced by corticosteroid withdrawal. Can Respir J (2006) 0.93
Measuring bronchitis in airway diseases: clinical implementation and application: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest (2010) 0.90
TRAF6 specifically contributes to FcepsilonRI-mediated cytokine production but not mast cell degranulation. J Biol Chem (2008) 0.89
Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can Respir J (2011) 0.89
Aging in the absence of TLR2 is associated with reduced IFN-gamma responses in the large intestine and increased severity of induced colitis. J Leukoc Biol (2008) 0.89
Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells. J Leukoc Biol (2008) 0.89
Persistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposure. Respir Res (2014) 0.89
What is an "eosinophilic phenotype" of asthma? J Allergy Clin Immunol (2013) 0.88
Monoclonal antibodies for the treatment of refractory asthma. Curr Opin Pulm Med (2014) 0.87
Targeted therapy of bronchitis in obstructive airway diseases. Pharmacol Ther (2013) 0.87
Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands. FASEB J (2011) 0.87
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial. Thorax (2012) 0.86
Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients. BMC Infect Dis (2002) 0.86
Change in forced expiratory volume in 1 second after sham bronchoconstrictor in suggestible but not suggestion-resistant asthmatic subjects: a pilot study. Psychosom Med (2003) 0.86
Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa. Infect Immun (2003) 0.85
Changing pattern of sputum cell counts during successive exacerbations of airway disease. Respir Med (2007) 0.85
Association between proximity to major roads and sputum cell counts. Can Respir J (2011) 0.85
Atmospheric remote sensing to detect effects of temperature inversions on sputum cell counts in airway diseases. Environ Res (2010) 0.85
PPAR ligands decrease human airway smooth muscle cell migration and extracellular matrix synthesis. Eur Respir J (2012) 0.84
The effect of omega-3 fatty acids on bronchial hyperresponsiveness, sputum eosinophilia, and mast cell mediators in asthma. Chest (2015) 0.84
Sputum hyaluronan and versican in severe eosinophilic asthma. Int Arch Allergy Immunol (2012) 0.84
The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta-analysis. Pol Arch Med Wewn (2008) 0.84
Zebrafish mast cells possess an FcɛRI-like receptor and participate in innate and adaptive immune responses. Dev Comp Immunol (2010) 0.83
MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer. Cancer Res (2013) 0.83
Cost analysis of monitoring asthma treatment using sputum cell counts. Can Respir J (2008) 0.83
Aryl hydrocarbon receptor-dependent retention of nuclear HuR suppresses cigarette smoke-induced cyclooxygenase-2 expression independent of DNA-binding. PLoS One (2013) 0.82
Quantitative sputum cell counts to monitor bronchitis: a qualitative study of physician and patient perspectives. Can Respir J (2013) 0.82
Expiratory flows and airway inflammation in elderly asthmatic patients. Respir Med (2011) 0.81
Mast cells and IgE activation do not alter the development of oral tolerance in a murine model. J Allergy Clin Immunol (2012) 0.81
Serum periostin as a marker of T(H)2-dependent eosinophilic airway inflammation. J Allergy Clin Immunol (2012) 0.81
Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells. Am J Pathol (2010) 0.81
Predictors of interleukin-33 and thymic stromal lymphopoietin levels in cord blood. Pediatr Allergy Immunol (2015) 0.80
Human mast cells induce caspase-independent DNA fragmentation in leukemic T cells. Oncol Rep (2003) 0.80
The gut microbiota of toll-like receptor 2-deficient mice exhibits lineage-specific modifications. Environ Microbiol Rep (2009) 0.80
Antiinflammatory effects of long-acting beta2-agonists in patients with asthma: a systematic review and metaanalysis. Chest (2009) 0.80
Airway responsiveness to indirect challenges in COPD. COPD (2010) 0.79
Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice. Immunobiology (2008) 0.79
Proximity to major roadways is a risk factor for airway hyper-responsiveness in adults. Can Respir J (2012) 0.79
Cystic fibrosis transmembrane conductance regulator gene abnormalities in patients with asthma and recurrent neutrophilic bronchitis. Can Respir J (2012) 0.79
Relationship between sputum eosinophilia and sinus disease in patients with eosinophilic bronchitis. Am J Rhinol Allergy (2014) 0.79
Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma. Respir Med (2013) 0.79
A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sources. J Immunol Methods (2012) 0.78
Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma. Expert Rev Respir Med (2015) 0.78
Lipid and smoker's inclusions in sputum macrophages in patients with airway diseases. Respir Med (2011) 0.77
Sputum neutrophilia can mask eosinophilic bronchitis during exacerbations. Can Respir J (2007) 0.77
When are biomarkers useful in the management of airway diseases? Pol Arch Med Wewn (2013) 0.77
Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M. Respir Res (2015) 0.76
Associations between airway hyperresponsiveness, obesity and lipoproteins in a longitudinal cohort. Clin Respir J (2012) 0.76
Reproducibility, validity, and responsiveness of cell counts in blown nasal secretions. Allergy Rhinol (Providence) (2011) 0.76
Glucocortiosteroid subsensitivity and asthma severity. Curr Opin Pulm Med (2017) 0.76